COVID-19 drugs invention using deep neural network models: an artificial intelligence approach Online publication date: Fri, 13-Aug-2021
by Pamir Roy; S.K. Tamang
International Journal of Intelligent Engineering Informatics (IJIEI), Vol. 9, No. 2, 2021
Abstract: The Covid-19 disease caused by the novel Corona Virus (SARS-2) spread like a wildfire and scientists across the whole world have been trying to find a cure for the disease and as such resorted to all methods available. The tool of artificial intelligence (AI) and data science has proven very useful in this regard for rapid drug invention and development. In this paper, tending along the same line, four different deep neural networks (DNNs) based models (bi-directional long short-term memory (LSTM) with attention, constrained graph variational autoencoders (CGVAE), edge memory neural network (EENN) and connectivity map (CMAP) based DNN have been proposed for usage in drug Invention of highly effective lead molecules for the disease COVID-19. The models have been evaluated and performed well with the highest performance given by the bi-directional LSTM model with validity of 98.7%, uniqueness of 99.8% and originality of 97.4%.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Intelligent Engineering Informatics (IJIEI):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook